Author: "Zimu Gong" / Journal: blood cancer journal - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Zimu Gong"' showing total 3 results

Start Over Author "Zimu Gong" Journal blood cancer journal

Author: Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D’Souza, and Meera Mohan
Subjects: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published: 2024
Full Text: View/download PDF

Author: Sanam Loghavi, W Yang, Wei Lien Wang, Hagop M. Kantarjian, Jorge E. Cortes, Lan Zheng, Joseph D. Khoury, Guiling Tang, R. Luthra, Shimin Hu, Zimu Gong, and L. J. Medeiros
Subjects: Adult, Male, Disease free survival, Adolescent, Fusion Proteins, bcr-abl, Aftercare, Biology, Disease-Free Survival, 03 medical and health sciences, Bcr abl1, Myelogenous, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, medicine, Humans, Letter to the Editor, Survival rate, Aged, Aged, 80 and over, Myeloid leukemia, Hematology, Middle Aged, medicine.disease, Fusion protein, Survival Rate, Leukemia, Oncology, 030220 oncology & carcinogenesis, Immunology, Cancer research, Female, 030215 immunology
Abstract: Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
Published: 2017

Author: H M Kantajian, Wei Lien Wang, Lan Zheng, L. J. Medeiros, H Xiong, Z. Chen, Keyur P. Patel, Shimin Hu, Jorge E. Cortes, and Zimu Gong
Subjects: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Antineoplastic Agents, Hematopoietic stem cell transplantation, Young Adult, 03 medical and health sciences, Myelogenous, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Transplantation, Homologous, Protein Kinase Inhibitors, Letter to the Editor, Aged, Aged, 80 and over, Hematology, business.industry, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Middle Aged, Prognosis, medicine.disease, Lymphoma, Transplantation, Leukemia, Haematopoiesis, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Immunology, Female, Blast Crisis, Transcriptome, business
Abstract: Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia
Published: 2017

Books, media, physical & digital resources

Searchworks